New Horizons in the Management of Dyslipidemias

Cardiology. 2024 Jan 30:1-2. doi: 10.1159/000535878. Online ahead of print.

Author

Walter F Riesen¹

Affiliation

¹ Emeritus Head of the Center of Laboratory Medicine, Kantonsspital, St. Gallen, Switzerland.

PMID: 38290480
DOI: 10.1159/000535878

No abstract available

Keywords: Cardiovascular outcomes; Cholesterol-lowering therapy; Dyslipidemia; HMGCoAreductase inhibition.